Cargando…
Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632816/ https://www.ncbi.nlm.nih.gov/pubmed/34863791 http://dx.doi.org/10.1053/j.gastro.2021.11.030 |
| _version_ | 1784607823480487936 |
|---|---|
| author | Trivedi, Mehul Gupta, Samir |
| author_facet | Trivedi, Mehul Gupta, Samir |
| author_sort | Trivedi, Mehul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8632816 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86328162021-12-01 Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? Trivedi, Mehul Gupta, Samir Gastroenterology Selected Summaries by the AGA Institute 2022-05 2021-12-01 /pmc/articles/PMC8632816/ /pubmed/34863791 http://dx.doi.org/10.1053/j.gastro.2021.11.030 Text en © 2022 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Selected Summaries Trivedi, Mehul Gupta, Samir Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? |
| title | Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? |
| title_full | Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? |
| title_fullStr | Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? |
| title_full_unstemmed | Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? |
| title_short | Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening? |
| title_sort | is promotion of fecal immunochemical testing “fit” to address covid-19 disruptions to colorectal cancer screening? |
| topic | Selected Summaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632816/ https://www.ncbi.nlm.nih.gov/pubmed/34863791 http://dx.doi.org/10.1053/j.gastro.2021.11.030 |
| work_keys_str_mv | AT trivedimehul ispromotionoffecalimmunochemicaltestingfittoaddresscovid19disruptionstocolorectalcancerscreening AT guptasamir ispromotionoffecalimmunochemicaltestingfittoaddresscovid19disruptionstocolorectalcancerscreening |